Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
5
×
startups
5
×
deals
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
fda
generic drugs
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston
drug prices
eli lilly
ipo
scott gottlieb
What
drugs
5
×
bio
new
roundup
aims
medicines
pharmaceutical
research
ahead
appetite
approach
asco
backed
bails
based
biotech
black
brand
branded
bread
bridgebio
butter
buyout
called
cancer
capital
car
cash
cause
ceo
choices
commissioner
consumers
costly
counterweight
debuts
develop
developing
diabetes
diamond’s
Language
unset
Current search:
startups
×
drugs
×
" new york top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More